Helius Medical Technologies (HSDT) to Release Quarterly Earnings on Wednesday

Helius Medical Technologies (NASDAQ:HSDT) is expected to be issuing its quarterly earnings data before the market opens on Wednesday, March 26th. Analysts expect the company to announce earnings of ($0.94) per share and revenue of $0.10 million for the quarter.

Helius Medical Technologies Stock Performance

Shares of NASDAQ HSDT opened at $0.43 on Monday. The firm’s 50 day moving average price is $0.57 and its 200-day moving average price is $0.60. The company has a market cap of $1.60 million, a PE ratio of -0.07 and a beta of 1.62. Helius Medical Technologies has a 52-week low of $0.37 and a 52-week high of $7.19.

About Helius Medical Technologies

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.